May 19th 2024
With agents like semaglutide and tirzepatide becoming household drug names, Peterson discusses the short-term future of incretin drug development.
Experts Debate Beta-Blocker Use With Simultaneous AFib and Heart Failure
August 3rd 2017Despite the results of a large-scale trial, some experts questioned the use of beta-blockers for patients that suffered from heart failure and simultaneous AFib when in the presence of beta-adverse medications, like amiodarone.